Medical Digest & Congress Report

Marc P. Bonaca explains semaglutide significantly improved maximal walking distance in people with symptomatic peripheral arterial disease and type 2 diabetes in a trial designed to evaluate the use of a GLP-1 agonist to manage PAD, according to a study presented at the American College of Cardiology’s Annual Scientific Session.

Video: https://medicaldigest.org/scientific-contents/interview:semaglutide-improves-walk-distance-pad-patients-diabetes

Michael J. Reardon explains the new five-year data suggest transcatheter aortic valve replacement with a supra-annular, self-expanding valve is a safe and effective alternative to surgical aortic valve replacement when treating low-risk patients. In fact, hemodynamic data after five years consistently favors a transcatheter approach, according to a study presented at the American College of Cardiology’s Annual Scientific Session.

Video: https://medicaldigest.org/scientific-contents/interview:tavr-comparable-open-heart-surgery-after-5-years-low-risk-patients

Darren K. McGuire explains people taking an oral formulation of semaglutide were 14% less likely than those taking a placebo to experience cardiovascular death, heart attack or stroke after an average follow-up of four years, according to a study presented at the American College of Cardiology’s Annual Scientific Session.

Video: https://medicaldigest.org/scientific-contents/interview:oral-semaglutide-reduces-cardiovascular-events-14-four-years

Joo-Yong Hahn shares his insights on the research presented at the American College of Cardiology's Annual Scientific Session. People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel rather than aspirin as their long-term antiplatelet therapy, according to Research.

Video: https://medicaldigest.org/scientific-contents/interview:research-shows-clopidogrel-better-long-term-therapy-aspirin-after-pci-report-acc25

Isabelle Mahé shares her insights API-CAT trial were presented at the American College of Cardiology’s Annual Scientific Session.

Video: https://medicaldigest.org/scientific-contents/interview:low-dose-apixiban-comparable-full-dose-preventing-vte-recurrence-patients-cancer

Eileen M. Handberg, PhD, ARNP, FACC and C. Noel Bairey Merz, MD, FACC, FAHA shares their insights on the WARRIOR study, presented at the American College of Cardiology Scientific Session.

Video: https://medicaldigest.org/scientific-contents/interview:warrior-study-intensive-medical-therapy-does-not-help-or-harm-women-chest-pain

Michael Gnant have been the Co-Chair of the highly successful, annual St Gallen Breast Cancer Conference in Vienna, and chaired a session about the latest advances of CDK4/6 inhibitor treatment in HR+/HER2− early breast cancer, focusing on risk of recurrence.

Video: https://medicaldigest.org/scientific-contents/interview:redefining-risk-recurrence-latest-advances-cdk46-inhibitors-hrher2-early-breast-cancer

Sami Timimi indicated in his presentation at the RCPsych in Scotland Winter Conference that formal psychiatric diagnostic systems should be abolished. In our interview he explains why psychiatric labels do more harm than good.

Video: https://medicaldigest.org/scientific-contents/interview:why-there-no-such-thing-psychiatric-diagnosis

Edoardo Ostinelli, Senior Researcher & Deputy Lead of Oxford Precision Psychiatry Lab at the Department of Psychiatry, University of Oxford, UK. He is the first author of a recently published article in Lancet Psychiatry about ADHD in adults. How important is this question? How many patients suffer from the disease? We asked him about the study.

Video: https://medicaldigest.org/scientific-contents/interview:comparative-efficacy-and-acceptability-pharmacological-psychological-and-neurostimulatory-interventions-adhd-adults-systematic-review-and-component-network-meta-analysis

Sven Bölte, professor of child and adolescent psychiatric science at Karolinska Institute, Stockholm, Sweden, renowned expert of neurodevelopmental disorders. He is the first author of a recently published article in Neuroscience & Biobehavioral Reviews about social cognition in autism and ADHD. We asked him about the study.

Article: Social cognition in autism and ADHD

Video: https://medicaldigest.org/scientific-contents/interview:social-cognition-autism-and-adhd